D8X-23635-52957
2 vaccinations
3 coded responses
22 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 024 / MA
- Registered
- 2021-11-17
- Relationship
- Child or adolescent in my care
- Guardian
- YVQ-17152-44169
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-17
Registered in v-safe
-
2021-11-17
Dose 1 — Pfizer-BioNTech
- 2021-11-17
-
2021-11-18
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · Headache, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-19
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-11-20
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-12-03
-
2021-12-08
Dose 2 — Pfizer-BioNTech
- 2021-12-08
-
2021-12-09
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Irritability — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: IrritableMedDRA releases: 2024-11 · check-in free text available
-
2021-12-11
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Initial insomnia — Feeling: GoodFree text: Some difficulty falling asleepMedDRA releases: 2024-11 · check-in free text available
- 2021-12-12
- 2021-12-14
- 2021-12-17
- 2021-12-22
- 2021-12-29
-
2022-01-05
Survey response — day 28, dose 2, dependentMedDRA: SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Tested positive for covid-19.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-05
Report sent to call center — day 28, dose 2, dependentBe unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-10
- 2022-01-12
- 2022-01-19
- 2022-03-11
- 2022-06-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-17 | Pfizer-BioNTech | No |
| 2 | 2021-12-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-05 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Irritable
Systemic reaction (other): Some difficulty falling asleep
Release 10 — day 28, dose 2, dependent
Symptoms: Tested positive for covid-19.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Initial insomnia | · | · | ✓ |
| SRO | Irritability | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release